Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
This is a list of nominated substances that may present significant safety risks in compounding
Price range: $294.60 through $410.00 AOD9604 is a peptide therapy derived from a specific 15-amino acid region of growth hormone (GH), originally developed as a treatment for obesity
The candidate has shown encouraging Phase 1 results, positioning Amgen as an emerging competitor in the next generation of anti-obesity drugs
Clinical human trial data is limited, and BPC-157 is not approved by any regulatory authority for human therapeutic use
Age-related decline in NAD+ can cause low energy and poor cognition
US$ 22.78
US$ 21.95
US$ 26.89
US$ 24.55
US$ 24.16
US$ 29.43
US$ 25.60
US$ 26.04
US$ 23.72
US$ 21.38
US$ 26.83
US$ 29.33
US$ 27.75
